{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:30:57Z","timestamp":1786991457745,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jamda.2024.105327","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:59:29Z","timestamp":1730192369000},"page":"105327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reducing the Inappropriate Use of Antipsychotics in Long-Term Care: Strategies for Success"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8970-597X","authenticated-orcid":false,"given":"Ahmed","family":"Vanker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"de Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Milijasevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105327_bib4","series-title":"QMENTUM GLOBAL\u2122 FOR LONG-TERM CARE Assessment Manual 210-01.001.124.24 V:1","year":"2024"},{"key":"10.1016\/j.jamda.2024.105327_bib5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/appi.ajp.2012.12030342","article-title":"Atypical antipsychotic use in patients with dementia: managing safety concerns","volume":"169","author":"Steinberg","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2024.105327_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jamda.2024.105327_bib8","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jamda.2024.105327_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2024.105327_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2040622316658463","article-title":"Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses","volume":"7","author":"Tampi","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jamda.2024.105327_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group","volume":"60","author":"Katz","year":"1999","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2024.105327_bib14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group","volume":"57","author":"Street","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jamda.2024.105327_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/JGP.0b013e318165db77","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease","volume":"16","author":"Streim","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105327_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S1041610219002011","article-title":"Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project","volume":"32","author":"Harrison","year":"2020","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2024.105327_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study","volume":"161","author":"Hwang","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2024.105327_bib18","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2024.105327_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105327_bib20","series-title":"Conceptual framework for the international classification for patient safety \u2013 Version 1.1 Final Technical Report [PDF]","year":"2009"},{"key":"10.1016\/j.jamda.2024.105327_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamainternmed.2021.0224","article-title":"Assessment of psychotropic drug prescribing among nursing home residents in Ontario, Canada, during the COVID-19 pandemic","volume":"181","author":"Stall","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2024.105327_bib24","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jamda.2020.09.007","article-title":"The impact of COVID-19 measures on well-being of older long-term care facility residents in The Netherlands","volume":"21","author":"Van der Roest","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105327_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.578015","article-title":"Behavioral and psychological effects of Coronavirus disease-19 Quarantine in patients with dementia","volume":"11","author":"Cagnin","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jamda.2024.105327_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jamda.2019.07.025","article-title":"Optimizing prescribing of antipsychotics in long-term care (OPAL): a Stepped-Wedge trial","volume":"21","author":"Kirkham","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105327_bib28","series-title":"Instruction manual for the Cohen-Mansfield Agitation Inventory (CMAI)","author":"Cohen-Mansfield","year":"1991"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024007497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024007497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T20:00:43Z","timestamp":1735070443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024007497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1525861024007497"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105327","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the Inappropriate Use of Antipsychotics in Long-Term Care: Strategies for Success","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105327"}}